£77.82

Springer Preoperative (Neoadjuvant) Chemotherapy: 103 (Recent Results in Cancer Research, 103)

Price data last checked 50 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 41 days • 41 data points (No recent data available)

Historical
Generating forecast...
£77.82 £77.64 £77.68 £77.72 £77.76 £77.80 £77.84 25 January 2026 04 February 2026 14 February 2026 24 February 2026 06 March 2026

Price Distribution

Price distribution over 41 days • 1 price levels

Days at Price
41 days 0 10 21 31 41 £78 Days at Price

Price Analysis

Most common price: £78 (41 days, 100.0%)

Price range: £78 - £78

Price levels: 1 different prices over 41 days

Description

Despite recent advances in adjuvant therapies of cancer, the regi mens of postoperative adjuvant chemotherapy treatment which are presently available fail to cure the majority of cancer patients. Pre operative (neoadjuvant) chemotherapy represents a new approach in drug scheduling, based on sound theoretical, pharmacokinetic, and experimental principles. The preoperative timing of chemotherapy before definitive sur gery is not a minor change in the therapy of cancer. To be successful, large numbers of practitioners and their patients must participate. Substantial alterations of many aspects of the present management of cancer will have to follow. Therefore, before such therapy can be fully and routinely implemented, results of the novel treatment and its rationale have to be carefully evaluated. In preoperative treatment, other features will likely gain impor tance. For the first time, clinicians have a chance to follow the in vivo response of the tumor exposed to preoperative chemotherapy. The subsequent histological assessment of the tumor sample may likely become an important prognostic guide, permitting more re fined individual approaches to the planning of postoperative adju vant treatment. The value of such a treatment strategy can already be appreciated in the clinical setting, as seen from the therapy of osteosarcoma. Furthermore, preoperative chemotherapy might render previously inoperable tumors operable and hence resectable with a curative intention. The preoperative reduction of tumor bulk may also effectively decrease the need for more radical operations, permitting a more uniform adoption of conservative surgery.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Springer Surgical Oncology: 90 - Cancer Treatment and Research
94% match

Springer Surgical Oncology: 90 - Cancer Treatment and Research

Springer

£118.03 01 Mar 2026
Surgical Oncology: 90 (Cancer Treatment and Research, 90)
94% match

Surgical Oncology: 90 (Cancer Treatment and Research, 90)

Springer

£329.06 13 Jan 2026
Surgical Oncology: An Algorithmic Approach
93% match

Surgical Oncology: An Algorithmic Approach

Springer

£153.10 11 Jan 2026
Springer Cancer Chemotherapy Volume 36 - Research Series
93% match

Springer Cancer Chemotherapy Volume 36 - Research Series

Springer

£113.25 05 Mar 2026
Springer Cancer Chemotherapy Vol 36 - Clinical Developments
93% match

Springer Cancer Chemotherapy Vol 36 - Clinical Developments

Springer

£129.94 04 Mar 2026
Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)
93% match

Regional Chemotherapy: Clinical Research and Practice (Current Clinical Oncology)

Humana

£85.07 13 Apr 2026
Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)
93% match

Supportive Care in Cancer Therapy: 13 (Cancer Treatment and Research, 13)

Springer

£215.71 11 Jan 2026
Comparative Effectiveness in Surgical Oncology: Key Questions and How to Answer Them: 164 (Cancer Treatment and Research, 164)
93% match

Comparative Effectiveness in Surgical Oncology: Key Questions and How to Answer Them: 164 (Cancer Treatment and Research, 164)

Springer

£90.85 08 Jan 2026
Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)
93% match

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Springer

£146.40 25 Jan 2026
Surgical Oncology: A Practical and Comprehensive Approach
93% match

Surgical Oncology: A Practical and Comprehensive Approach

Springer

£139.00 11 Jan 2026
Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)
93% match

Chemosensitivity Testing in Oncology: 161 (Recent Results in Cancer Research, 161)

Springer

£83.52 27 Feb 2026
Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)
93% match

Clinical Evaluation of Antitumor Therapy: 46 (Developments in Oncology, 46)

Springer

£165.33 18 Apr 2026
Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment
93% match

Chemotherapy Protocols and Infusion Sequence: Schedule Consideration in Cancer Treatment

£72.98 09 Jan 2026
Minimally Invasive Surgical Oncology: State-of- the-Art Cancer Management
93% match

Minimally Invasive Surgical Oncology: State-of- the-Art Cancer Management

Springer

£197.12 08 Mar 2026
Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)
93% match

Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures: 13 (Cancer Growth and Progression, 13)

Springer

£110.00 10 Mar 2026
Cancer Immunotherapy: Immune Suppression and Tumor Growth
93% match

Cancer Immunotherapy: Immune Suppression and Tumor Growth

Academic Press

£77.00 24 Feb 2026
Springer - Immunotherapy of Cancer: An Innovative Treatment
92% match

Springer - Immunotherapy of Cancer: An Innovative Treatment

Springer

£110.34 18 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
92% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£108.91 20 Apr 2026
Springer - Novel Immunotherapeutic Approaches to Cancer Treatment
92% match

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer

£113.48 18 Apr 2026
Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy
92% match

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Springer

£54.12 08 Mar 2026
Ovarian Cancer: 23 (Cancer Treatment and Research, 23)
92% match

Ovarian Cancer: 23 (Cancer Treatment and Research, 23)

Springer

£106.06 24 Jan 2026
Vascular Surgery in Oncology
92% match

Vascular Surgery in Oncology

£110.13 31 Jan 2026
New Technologies in Surgical Oncology (Updates in Surgery)
92% match

New Technologies in Surgical Oncology (Updates in Surgery)

Springer

£93.88 24 Feb 2026
Trends in Chemotherapy Research
92% match

Trends in Chemotherapy Research

£90.22 25 Jan 2026